| DataM Intelligence AUSTIN, Texas and TOKYO, Nov. 18, 2025 /PRNewswire/ -- According to DataM Intelligence, the Primary Biliary Cholangitis (PBC) Treatment Market reached USD 1.33 billion in 2024 and ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. A number of new treatments have become ...

A new study suggests that the cholesterol-regulating protein PCSK9 may serve as a sensitive early biomarker for autoimmune ...

PHOENIX — Seladelpar, a first-in-class, selective peroxisome proliferator-activated receptor delta agonist, shows significant improvement across key pruritus outcomes in patients with primary biliary ...

THERE are few things as satisfying as scratching an itch. But when your itch keeps recurring and starts to affect your day-to ...

People with blood type A may be at higher risk of developing autoimmune liver disease, resulting in potentially ...

People with a certain blood group may face a higher chance of liver disease as shown in a recent study. Know the risks and ...

Certain blood types may influence the risk of developing serious liver conditions, with recent research highlighting links between inherited blood groups and autoimmune liver diseases. Keep reading ...

Many people with primary biliary cholangitis are not receiving recommended alkaline phosphatase monitoring. Learn more about ...

In this video, Nancy S. Reau, MD, FAASLD, AGAF, discusses long-term data from the ELATIVE open-label extension trial of Iqirvo in patients with primary biliary cholangitis.Results presented at The ...

Findings indicate blood group A elevates the risk of primary biliary cholangitis, suggesting ABO group analysis could aid in ...

Clinically diagnosed pruritus significantly affected fatigue and antidepressant use in adults with primary sclerosing cholangitis (PSC), based on data from nearly 5000 patients presented at The Liver ...